Johnson & Johnson's Ethicon Subsidiary Ordered to Pay $76.56 Million in AI Imaging Contract Breach

Jul 11, 2025 10:30 CST Updated 10:30

Johnson & Johnson

Medical Device R&D and Manufacturer

ChemImage

A research company providing chemical and biological application software

According to overseas reports, Johnson & Johnson in one caseLost the lawsuit for breach of contract. In May this yearUnited States District Court for the Southern District of New YorkDetermination that Johnson & Johnson (Ethicon) breached the contract,Therefore, the judgeJesse M. FurmanThe verdict was officially issued this week.CourtJudgment on Johnson & Johnson (Ethicon to Pay ChemImage $76.56 Million in Compensation.

Court Judgement$76.56 millionThe compensation includes two parts: one part is$40 million contract fee, another part is$37 million in compensation (including intellectual property impairment compensation). Among themDeduct the $510,000 that both parties confirmed ChemImage has obtained through asset sales.

Introduction to ChemImage

ChemImage is an innovative medical device company dedicated to making the world healthier and safer through significant breakthroughs in chemical imaging technology.It is developing an AI-driven software that allows surgeons to "visualize" and interpret the movements of robotic surgical instruments. These images will assist surgeons in evaluating damaged or cancerous tissues in real time.

Background of the Dispute

Facing increasingly fierce market competition in surgical robots, especially needing to faceIntuitive, this behemoth. Johnson & Johnson needs to add innovative selling points for its surgical robot, so in 2019, it...ChemImage Corporation has reached a cooperation agreement and signedContracts worth billions of dollars.

After signing the contract, Johnson & JohnsonChemImage prepaid $7 million. Subsequently, both parties began to accelerate the promotion of cooperation, but unfortunately, the project progress did not go as hoped.By early 2023, Johnson & Johnson found that the integration of ChemImage software with robotics had not met expectations (the project was severely delayed), and Johnson & Johnson believed there was no commercially viable product in sight, leading to the beginning of the breakdown in their collaboration.

InMarch 6, 2023, Johnson & JohnsonTerminating the contract on the grounds of "unfinished nodes," butChemImage does not recognize this. Therefore, ChemImage accused Johnson & Johnson of breach of contract and filed a lawsuit against Johnson & Johnson for tortious interference with contract. Both parties are striving to present evidence favorable to their respective sides.

Johnson & Johnson lost the case eventually. However, it remains unknown whether Johnson & Johnson will appeal. After all, they have spent hundreds of millions of dollars so far, and now they have to pay nearly 80 million dollars in compensation, which makes them feel reluctant.